Get started
Author

Yuliya Lytvyn

Sodium Glucose Cotransporter-2 Inhibition in Heart Failure
2017 · Yuliya Lytvyn, Petter Bjornstad, et al. · Circulation · 459
PDF
Glycosuria-mediated urinary uric acid excretion in patients with uncomplicated type 1 diabetes mellitus
2014 · Yuliya Lytvyn, Marko Škrtić, et al. · American Journal of Physiology-Renal Physiology · 173
The New Biology of Diabetic Kidney Disease—Mechanisms and Therapeutic Implications
2019 · Yuliya Lytvyn, Petter Bjornstad, et al. · Endocrine Reviews · 165
PDF
Characterisation of glomerular haemodynamic responses to SGLT2 inhibition in patients with type 1 diabetes and renal hyperfiltration
2014 · Marko Škrtić, Gary K. Yang, et al. · Diabetologia · 159
PDF
Uric Acid as a Biomarker and a Therapeutic Target in Diabetes
2015 · Yuliya Lytvyn, Bruce A. Perkins, et al. · Canadian Journal of Diabetes · 138
Sodium–glucose cotransporter 2 inhibition and cardiovascular risk reduction in patients with type 2 diabetes: the emerging role of natriuresis
2016 · Harindra Rajasekeran, Yuliya Lytvyn, et al. · Kidney International · 129
Dapagliflozin in focal segmental glomerulosclerosis: a combined human-rodent pilot study
2017 · Harindra Rajasekeran, Heather N. Reich, et al. · American Journal of Physiology-Renal Physiology · 87
Assessment of urinary microparticles in normotensive patients with type 1 diabetes
2016 · Yuliya Lytvyn, Fengxia Xiao, et al. · Diabetologia · 76
PDF
Renal and Vascular Effects of Combined SGLT2 and Angiotensin-Converting Enzyme Inhibition
2022 · Yuliya Lytvyn, Karen Kimura, et al. · Circulation · 71
PDF
Atherosclerosis and Microvascular Complications: Results From the Canadian Study of Longevity in Type 1 Diabetes
2018 · Julie A. Lovshin, Petter Bjornstad, et al. · Diabetes Care · 61
PDF
Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetes
2018 · Julie A. Lovshin, Geneviève Boulet, et al. · JCI Insight · 56
PDF
Urinary adenosine excretion in type 1 diabetes
2017 · Harindra Rajasekeran, Yuliya Lytvyn, et al. · American Journal of Physiology-Renal Physiology · 56
Glycolytic lactate in diabetic kidney disease
2024 · Manjula Darshi, Luxcia Kugathasan, et al. · JCI Insight · 55
Neuropathy and presence of emotional distress and depression in longstanding diabetes: Results from the Canadian study of longevity in type 1 diabetes
2017 · Johnny-Wei Bai, Leif E. Lovblom, et al. · Journal of Diabetes and its Complications · 51
Renal hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in hyperfiltering people with type 1 diabetes and people with type 2 diabetes and normal kidney function
2020 · Erik J.M. van Bommel, Yuliya Lytvyn, et al. · Kidney International · 47
The Gomez equations and renal hemodynamic function in kidney disease research
2016 · Petter Bjornstad, Marko Škrtić, et al. · American Journal of Physiology-Renal Physiology · 47
Markers of Kidney Injury, Inflammation, and Fibrosis Associated With Ertugliflozin in Patients With CKD and Diabetes
2021 · Hongyan Liu, Vikas S. Sridhar, et al. · Kidney International Reports · 46
Mineralocorticoid Antagonism and Diabetic Kidney Disease
2019 · Yuliya Lytvyn, Lucas C. Godoy, et al. · Current Diabetes Reports · 46
PDF
Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatment
2020 · Muskaan Sachdeva, Asfandyar Mufti, et al. · Journal of the American Academy of Dermatology · 44
PDF
The relationship between urinary renin-angiotensin system markers, renal function, and blood pressure in adolescents with type 1 diabetes
2016 · Kevin D. Burns, Yuliya Lytvyn, et al. · American Journal of Physiology-Renal Physiology · 39
Treatment Outcomes of IL-17 Inhibitors in Hidradenitis Suppurativa: A Systematic Review
2021 · Nadia Kashetsky, Asfandyar Mufti, et al. · Journal of Cutaneous Medicine and Surgery · 37
Changes in Cardiovascular Biomarkers Associated With the Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor Ertugliflozin in Patients With Chronic Kidney Disease and Type 2 Diabetes
2021 · Patrick R. Lawler, Hongyan Liu, et al. · Diabetes Care · 35
PDF
Targeting Interleukin 13 for the Treatment of Atopic Dermatitis
2023 · Yuliya Lytvyn, Melinda Gooderham · Pharmaceutics · 34
PDF
Changes in plasma and urine metabolites associated with empagliflozin in patients with type 1 diabetes
2021 · Hongyan Liu, Vikas S. Sridhar, et al. · Diabetes Obesity and Metabolism · 34
New and old agents in the management of diabetic nephropathy
2016 · Yuliya Lytvyn, Petter Bjornstad, et al. · Current Opinion in Nephrology & Hypertension · 34
Works count: 186
Citation count: 3,202
H-index: 30
I10-index: 65
Year
Topic
Type